|
PF-58759 |
EBROPINEM 1 g Polvo para solución inyectable |
2025-11-11 |
|
Puniska Healthcare Pvt. Ltd. |
India
|
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59353 |
REDUXIFEN 1.00% P/V Solución inyectable para infusión |
2026-04-26 |
|
Puniska Healthcare Pvt. Ltd. |
India
|
Diproex |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59381 |
EBROXON 1 g Polvo Para Solución Inyectable |
2026-05-03 |
|
Puniska Healthcare Pvt. Ltd. |
India
|
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60642 |
BECTAMET 500 mg / 100 mL Solución inyectable para infusión |
2027-01-21 |
|
Puniska Healthcare Pvt. Ltd. |
India
|
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60643 |
OBROLEV 500 mg / 100 mL Solución inyectable para infusión |
2027-01-21 |
|
Puniska Healthcare Pvt. Ltd. |
India
|
Centrino Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-33727 |
OXYCONTIN 10 mg Comprimidos recubiertos de liberación prolongada |
2024-08-25 |
|
Mundipharma Laboratories Gmbh |
Estados Unidos de América
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22276 |
OXYCONTIN 20 mg Comprimidos recubiertos de liberaciòn prolongada |
2024-10-21 |
|
Mundipharma Laboratories Gmbh |
Estados Unidos de América
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22275 |
OXYCONTIN 40 mg comprimidos recubiertos de liberación prolongada |
2019-10-21 |
|
Agencias J. I. Cohen |
Estados Unidos de América
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Agencias J.I. Cohen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50360 |
CLOROQUINA FOSFATO 250 mg Tabletas |
2019-07-17 |
|
Marpel Pharma S.A. |
India
|
Italpharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-47414 |
PARACETAMOL Marpelpharma 500 mg Tabletas |
2017-06-06 |
|
Italpharma |
India
|
Italpharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|